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A b s t r a c t
Reporting of the results of routine laboratory blood culture tests to clinicians is vital to the patients’ early treatment. This study aimed 
to perform identification and antibiotic susceptibility tests of the blood cultures showing positive signals of microbial growth in the first 
12 hours of incubation by using centrifugation and Gram staining of 5 ml of liquid from the vial, thus achieving faster results. This study 
included 152 consecutively incubated blood culture samples showing positive microbial growth signals in the first 12 hours. The samples 
were centrifuged and then categorized into two groups (Gram-positive and Gram-negative) using Gram staining. Identification and anti-
biotic susceptibility tests were performed using an automated culture antibiogram device. For routine processing, media inoculated with 
positive blood culture were kept in the incubator for at least 24 hours. To compare the two methods in terms of the bacteria identification, 
matrix‐assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI‐TOF MS) of the growing colony was studied. By 
Gram staining, the same bacterial strains were obtained for 138 (92%) of the 152 samples, similar to the results of the procedures mentioned 
earlier. With the samples tested with both methods, the antibiotic susceptibility profiles were compared using the antibiogram results for 
1,984 samples that underwent the antibiotic testing. A 97.4% (for 1,934 antibiotic susceptibility assays) agreement was observed between 
the two methods. Comparing the results of the post-centrifugation Gram staining to those obtained for the specimens using routine pro-
cedures, the clinicians reported a high success rate (approximately 97%).
K e y  w o r d s: blood culture, Gram staining, antibiotic susceptibility test, rapid reporting, MALDI-TOF MS
Introduction
Bloodstream infections, especially in intensive care 
units, are among the most important causes of morbid-
ity and mortality despite the antimicrobial treatment. 
The early diagnosis and treatment of these infections 
is clinically vital (Durmaz et al. 2003; Ferreira et al. 
2011). For the proper identification and antibiotic 
susceptibility testing, the bacteria grown in blood cul-
ture bottles are sent to laboratories; the detection of 
bloodstream infections under the appropriate growth 
conditions, at the appropriate periods, and using the 
appropriate conventional methods constitute a signifi-
cant portion of microbiological testing. The recently 
developed automated systems have been shown to 
be suitable for bacterial culture, and upon detection 
of a  growth signal, clinicians can remove the bottles 
from the device and inoculate the sample into media. 
These media generally include resins or coal particles 
that absorb antimicrobial agents or other substances 
that inhibit bacterial growth and may be present in the 
patient’s blood sample (Morrell et al. 2005; Kirn et al. 
2014; Nataraj et al. 2016; Jacobs et al. 2017). Early and 
correct treatment of patients is essential for reducing 
morbidity and mortality.
For this reason, rapid identification of microorgan-
isms and antibiotic susceptibility testing is crucial. Due 
to Gram staining of microorganisms in blood cultures, 
their identification and antibiotic sensitivity results are 
obtained early, clinicians are informed quickly, and the 
patient is given the opportunity to start early antibiotic 
treatment. Continuous monitoring of automated blood 
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culture systems allows a positive blood culture to be 
detected within 6 to 24 hours of incubation (Morrell 
et al. 2005; Behera et al. 2010; Ferreira et al. 2011; Kirn 
et al. 2014; Nataraj et al. 2016).
In recent years, advances in the methods involving 
polymerase chain reaction and DNA sequencing have 
changed the nature of clinical microbiology laboratories. 
However, the lack of diagnostic tests that are fast, reli-
able, easy to use, and inexpensive, as well as applicable 
for use as diagnostic checkpoints is a significant limita-
tion (Tuite et al. 2014; Yis 2015; Caliendo and Hodinka 
2017). Although several molecular or proteomic meth-
ods (e.g., Matrix‐Assisted Laser Desorption/Ionization 
Time‐of‐Flight Mass Spectrometry [MALDI‐TOF MS]) 
exist that can be used to direct evaluation of specimens 
or colonies, the gold-standard methods with the highest 
sensitivity and safety still remain blood culture-based 
methods (Mamishi et al. 2005; Behera et al. 2010; Tuite 
et al. 2014; Yis 2015; Nataraj et al. 2016; Caliendo and 
Hodinka 2017; Jacobs et al. 2017).
This study aimed to use a different, faster-than-usual 
method, which involves centrifugation at 12 hours of 
bacterial culture to allow clinicians to rapidly (in less 
than 12  hours) complete the antibiotic susceptibility 
testing. It may be due to more accurate information 
about the Gram-staining characteristics of growing 
microorganisms via a positive signal of microbial 
growth in the incubator.
Experimental
Materials and Methods
Clinical samples. The study included 152  bot-
tles of blood culture (aerobic, pediatric blood culture 
vials, BD, USA), which gave positive signals in the first 
12 hours in the incubator (Bactec FX, BD, USA) out of 
2,455 blood culture samples sent from different clinics 
of our hospital to the Medical Microbiology Laboratory 
between August 2018 and July 2019. Of these 152 blood 
culture bottles, 102 were sent from intensive care units, 
31 from internal sciences clinics, and 19 from surgical 
sciences clinics. Of these, 130 belonged to adult patients 
(≥ 18 years old), and 22 belonged to pediatric patients 
(< 18 years old).
The rapid method. Centrifugation. Five ml of the 
inoculating fluid was taken from the positive blood cul-
ture vials, and, unlike in the routine procedure, the cen-
trifugation was conducted in a standard blood collec-
tion tube (BD Vacutainer 5.0 ml, BD, USA) at 2,000 rpm 
for 10 minutes. After centrifugation, the blood compo-
nents (erythrocytes, etc.) were placed under a gel, and 
the bacteria in the serum adhered to the gel to provide 
a gelatinous coating that formed a film layer. Then, the 
supernatant liquid remaining on the gel in the collec-
tion tube was slowly discharged. A small number of the 
bacteria collected in the form of a layer on the gel in 
the collection tube was removed with a cotton swab and 
spread on a sterile microscope slide for Gram staining.
Gram staining. After the serum fraction was 
removed, a few bacteria were taken from the bacterial 
film layer just above the gel. Then, a small volume of this 
layer was spread and air-dried on a slide. The air-dried 
preparations were subjected to Gram staining (Becerra 
et al. 2016) using a Gram-staining set (Moslab, Ankara, 
Turkey). For this, crystal violet was poured onto the 
slide, left for 2 minutes, and washed with water. Then, 
the Lugol solution was poured, left for 2 minutes, washed 
with water, then decolorized with alcohol and washed 
with water. Finally, diluted fuchsin was poured onto the 
slide, and after 30 seconds, the preparation was washed 
with water and allowed to air-dry. The preparations were 
then examined with a microscope with a 100 × objec-
tive. Based on the results of the study, the strains were 
defined as Gram-positive or Gram-negative (Figs. 1–4).
Identification and antibiotic susceptibility test-
ing using the rapid method. After Gram staining, the 
strains of Gram-positive and Gram-negative bacteria 
or yeast were picked from the gel with a cotton-tipped 
extruder. Bacteria of a concentration equivalent to 
a McFarland standard of 0.5–0.63 (for yeasts, 1.8–2.2) 
were diluted with the manufacturer’s identification 
solution (ID broth, BD, USA). Then, 0.5 μl of the dilu-
tion was transferred to the antibiotic susceptibility test 
solution (AST broth, BD, USA), and identification and 
antibiotic susceptibility tests were conducted using an 
automated identification and susceptibility testing sys-
tem (Phoenix 100, BD, USA) and the appropriate kits 
(GP ID/AST, GN ID/AST or YEAST ID, BD, USA). The 
tests run for an average of 8–12 hours, depending on 
the type of microorganism. The results were reported 
quickly within 24 hours by the clinician involved.
The routine procedures. For comparison, the 
micro organisms from bottled blood samples were also 
cultured on sheep blood agar (SBA), eosin methylene 
blue (EMB) agar, and some other media without 
centrifugation and routinely incubated at 37°C for 
18–24  hours. The next day, when sufficient growth 
was observed, routine Gram-staining and antibiotic 
susceptibility testing were performed. With the help of 
a sterile loop, a small volume of the colonies grown on 
the medium was taken and mixed in the identification 
broth (ID broth, BD, USA). Then, 0.5 μl of the dilution 
was transferred to the solution for antibiotic suscep-
tibility testing (AST broth, BD, USA). Both solutions 
were transferred to the appropriate kits. Identification 
and antibiotic susceptibility tests were conducted using 
the automated identification and susceptibility testing 
system (Phoenix 100, BD, USA), and the appropriate 
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Fig. 2. Microscopic appearance of Gram-positive bacteria
after Gram staining with the rapid method at a magnification
of 1000×.
Fig. 1. Microscopic appearance of Gram-positive bacteria
after Gram staining with the routine method at a magnification
of 1000×.
Fig. 3. Microscopic appearance of Gram-negative bacteria
after Gram staining with the routine method at a magnification
of 1000×.
Fig. 4. Microscopic appearance of Gram-negative bacteria
after Gram staining with the rapid method at a magnification
of 1000×.
kits (GP ID/AST or GN ID/AST, BD, USA). The tests 
were run for an average of 8–12 hours, depending on 
the type of microorganism. The results were reported 
quickly, within 24 hours, by the clinician involved.
MALDI-TOF MS Analysis. The samples were col-
lected with the aid of a sterile loop from colonies of 
microorganisms grown on the appropriate medium 
using a  routine method, and each bacterial or yeast 
isolate was transferred to a separate well on a distinct 
plate in the MALDI-TOF system. One microliter of 
70% formic acid (FA) (FA extraction solution, Bruker 
Daltonik GmbH, Germany) was added to the plate, and 
after drying at room temperature, 1 µl of α-cyano-4-
hydroxycinnamic acid matrix solution (HCCA) (IVD 
Matrix HCCA, Bruker Daltonik GmbH, Germany) 
was again dried at room temperature (20–25°C). The 
dried plates were placed in the instrument (MSP 96 
target polished steel, Bruker Daltonik GmbH, Ger-
many) and loaded onto the MALDI-TOF MS (Bruker, 
Germany) for analysis. At the end of the analysis, the 
reported microorganisms were recorded using a par-
ticular software system (IVD MALDI Biotyper, Bruker 
Daltonik GmbH, Germany) (Schulthess et al. 2014). For 
the scoring used in the identification, values were in 
the range from 0 to 3. Microorganisms with a score ≥ 2 
were evaluated as correctly identified at the genus and 
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Gram-positive cocci 107 (70.4)
Gram-negative bacilli  30 (19.7)
Gram-positive bacilli   9 (5.3)
Gram-positive cocci + Gram-negative bacilli   2 (1.3)
Yeast (Candida spp.)   4 (2.6)
Total number of samples 152 (100)
Table I
Distribution of microorganisms detected by Gram staining after
centrifugation according to the rapid method procedure.
n – number
Gram-staining result n (%)
species level. A score of 1.7–2 given to organisms indi-
cated a correct identification at the genus level. Organ-
isms with a score of < 1.7 were identified as those that 
required testing again.
Data analysis. In terms of identification, in the 
Phoenix 100 Expert System’s interpretation, organisms 
with a reliability > 90 were accepted as being correctly 
identified. Those with a value of < 90 were considered 
incorrectly identified. In terms of susceptibility, the 
minimum inhibitory concentration (MIC) values of 
the bacteria against the antimicrobials evaluated by 
both the rapid and routine method were translated 
into clinical categories (susceptible [S], intermediate [I], 
or resistant [R]) according to the Phoenix 100 Expert 
System’s interpretive criteria.
For comparison of the results of both methods, the 
Clinical and Laboratory Standards Institute (CLSI) M52 
Verification of Commercial Microbial Identification 
and Antimicrobial Susceptibility Testing System (Cam-
pigotto et al. 2018) was used. According to this methodo-
logy, the identification results were divided into three 
categories: not identified, misidentified (organism was 
incorrectly identified at the genus or species level [dis-
crepancy]), and full consistency (accurate identification 
at the same genus and species level by both methods). 
For the antibiotic susceptibility results, the discrepan-
cies were classified as minor errors (mEs: susceptible/
resistant versus intermediate susceptibility), major errors 
(MEs: false resistant, considered as resistant susceptibil-
ity by one method but susceptible by the other method), 
and very major errors (VMEs: false susceptibility).
Statistical analysis. The statistical analyses were 
performed using software (SPSS 15.0, IBM, USA). The 
results of the continuous data analyses were given as 
minimum, maximum, median, and mean values, and 
the results of some categorical variables were given as 
frequencies and percentages.
Results
A positive signal, which was a bacterial growth 
marker, was recorded for 152 bottles of blood culture 
included in the study. They were sent from 102 (67.1%) 
intensive care units (84 internal intensive care, nine 
coronary intensive care, and nine pediatric intensive 
care), 31 (20.4%) from internal clinics (15 internal med-
icine clinics, ten oncology/hematology clinics, and six 
pediatric clinics), and 19 (12.5%) from surgical clinics 
(10 general surgery clinics, seven pediatric surgery clin-
ics, and two gynecology clinics). Of the 152 samples, 
130 (85.5%) came from adult patients and 22 (14.5%) 
from pediatric patients. Of the patients, 82 (54%) were 
female, 70 (46%) were male, and the youngest patient 
was one year old, while the oldest was 89  years old 
(their mean age was 57.5). Because of the lack of blood-
based elements in the bacterial layer and the presence 
of a more significant number of microorganisms than 
usual, the images of the microorganisms obtained by 
microscopic examination following Gram staining after 
centrifugation were more satisfactory in terms of their 
quality and quantity than those obtained following 
Gram staining without centrifugation.
According to the results obtained, of the 152 samples 
included in the study, 150 (98.7%) contained only one 
type of bacteria. While 116 (77.3%) of these 150 strains 
stained as Gram-positive (107 cocci and nine bacilli), 
and 30 (20%) stained as Gram-negative bacilli. The 
remaining four strains (2.7%) stained as Gram-posi-
tive, but they were placed in a separate category because 
they were yeast. In the other two (1.3%) samples, two 
bacterial species (Escherichia coli and Staphylococcus 
aureus), one Gram-positive and one Gram-negative 
were detected. In the microscopic examination of 
the stained cells, these two specimens, that contained 
more than one type of microorganism, were not evalu-
ated because these bacteria could not be separately 
tested for antibiotic susceptibility and because the 
bacteria must be inoculated onto appropriate media. 
In other words, these two samples were passaged and 
ter minated 18–24 hours after incubation according to 
routine procedures.
For the identification and antibiotic susceptibility 
testing, 116 (77.3%) of the 150 microbial strains were 
analyzed using GP ID/AST kits because these strains 
were detected as being Gram-positive by Gram stain-
ing, and 30 (20%) strains evaluated using GN ID/AST 
kits because these strains were detected as being Gram-
negative by Gram staining. Furthermore, four samples 
were determined using a YEAST/ID kit because they 
were observed as yeast in the Gram staining (Table I).
According to the results obtained the following 
morning, of the 116  Gram-positive strains studied 
by MALDI-TOF MS analysis, 71 (61.2%) were identi-
fied as coagulase-negative Staphylococcus (CoNS), and 
seven (6.0%) were identified as Staphylococcus aureus 
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Gram-positive bacteria (total) 116 Gram-positive bacteria (total) 116
Staphylococcus aureus   7 (6.0) Staphylococcus aureus   8 (6.9)
MRSA: 2, MSSA: 5  MRSA: 3, MSSA: 5
Coagulase-negative Staphylococci  71 (61.2) Coagulase-negative Staphylococci
Staphylococcus epidermidis: 45  Staphylococcus epidermidis: 48  76 (65.5)
Staphylococcus hominis: 16  Staphylococcus hominis: 18
Staphylococcusschleiferi: 4  Staphylococcusschleiferi: 4
Staphylococcus haemolyticus: 2  Staphylococcus haemolyticus: 2
Staphylococcus capitis: 2  Staphylococcus capitis: 2
Staphylococcus warneri: 2  Staphylococcus warneri: 2
Enterococci  20 (17.2) Enterococci  20 (17.2)
Enterococcus faecalis: 18  Enterococcus faecalis: 18
Enterococcus faecium: 2   3 (2.6) Enterococcus faecium: 2   2 (1.8)
Arcanobacterium haemolyticum   3 (2.6) Arcanobacterium haemolyticum   2 (1.8)
Bacillus cereus/subtilis   2 (1.8) Bacillus subtilis   2 (1.8)
Dermacoccus nishinomiyaensis   4 (3.5) Dermacoccus nishinomiyaensis   2 (1.8)
Micrococcus luteus/lylae   3 (2.6) Micrococcus luteus/lylae   2 (1.8)
Corynebacterium amycolatum   3 (2.6) Corynebacterium amycolatum   2 (1.8)
Corynebacterium jeikeium  Corynebacterium jeikeium
Gram-negative bacteria (total)  30 Gram-negative bacteria (total)  30
Escherichia coli  15 (50) Escherichia coli  15 (50)
Pseudomonas aeruginosa   5 (16.7) Pseudomonas aeruginosa   5 (16.7)
Klebsiella pneumoniae   5 (16.7) Klebsiella pneumoniae   5 (16.7)
Stenotrophomonas maltophilia   3 (10.0) Stenotrophomonas maltophilia   3 (10.0)
Acinetobacter baumannii   2 (6.7) Acinetobacter baumannii   2 (6.7)
Yeasts   4 Yeasts   4
Candida parapsilosis   2 (50) Candida parapsilosis   2 (50)
Candida tropicalis   2 (50) Candida tropicalis   2 (50)
Table II
Distribution of bacteria identified by both methods at the genus and species level.
MRSA – methicillin-resistant Staphylococcus aureus; MSSA – methicillin-susceptible Staphylococcus aureus;
 n – number
Rapid method n (%) Routine method n (%)
(one isolate, identified as S. epidermidis, was, in fact, 
methicillin-resistant S. aureus [MRSA] as demonstrated 
with both the routine method and the MALDI-TOF 
system), while 20 (17.2%) were Enterococcus species. 
These values, when studied by the routine method, were 
as follows: 76 (65.5%), 8 (6.9%), and 20 (17.2%), respec-
tively. No isolates of vancomycin-resistant enterococci 
(VRE) were found in this study. In addition, 15 (50%) 
of Gram-negative isolates were identified as E. coli, five 
as P. aeruginosa, five as Klebsiella pneumoniae, three as 
Stenotrophomonas maltophilia, and two as Acinetobac-
ter baumannii. When the yeast isolates were analyzed 
using the appropriate kit (YEAST/ID, BD, USA) and 
the appropriate McFarland (1.8–2.2) standard (BD 
PhoenixSpec, BD, USA), the results obtained by both 
methods were found to be fully compatible (two of the 
four specimens were identified as Candida parapsilosis 
and the other two as Candida tropicalis) (Table II).
Two of the three strains identified as S. epider-
midis were identified by MALDI-TOF as Micrococcus 
luteus/lylae, and one was identified as Arcanobacterium 
haemolyticum. One isolate was identified as Corynebac-
terium amycolatum, which should have been identified 
as S. aureus. One of the two isolates, which should have 
been identified as Staphylococcus hominis, was identi-
fied as Bacillus cereus/subtilis, and the other was iden-
tified as Corynebacterium jeikeium. As a result, 138 
(92%) out of 150 isolates were correctly identified, 
while the number misidentified was only 12. In fact, 
all false identifications at the genus or species level were 
also associated with Gram-positive bacteria (Table III).
These values were compared with the identifica-
tion and antibiotic susceptibility results obtained by 
the routine procedures. According to this compari-
son, for 138 (92%) of the 150 strains studied, the same 
results for the identification testing were obtained using 
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Gram-positive bacteria 116 116 116
Staphylococcus aureus 0 0 8 8 7 8
Staphylococcus epidermidis 0 12 36 48 45 48
Staphylococcus hominis 0 2 16 18 16 18
Staphylococcusschleiferi 0 0 4 4 4 4
Staphylococcus haemolyticus 0 0 2 2 2 2
Staphylococcus capitis 0 0 2 2 2 2
Staphylococcus warneri 0 0 2 2 2 2
Enterococcus faecalis 0 0 18 18 18 18
Enterococcus faecium 0 0 2 2 2 2
Arcanobacterium haemolyticum 0 1 1 2 3 2
Bacillus cereus/subtilis 0 0 0 0 1 0
Bacillus subtilis 0 0 2 2 2 2
Dermacoccus nishinomiyaensis 0 0 2 2 2 2
Micrococcus luteus/lylae 0 1 1 2 4 2
Corynebacterium amycolatum 0 1 1 2 3 2
Corynebacterium jeikeium 0 1 1 2 3 2
Gram-negative bacteria 30 30 30
Escherichia coli 0 0 15 15 15 15
Pseudomonas aeruginosa 0 1 4 5 5 5
Klebsiella pneumoniae 0 0 5 5 5 5
Stenotrophomonas maltophilia 0 0 3 3 3 3
Acinetobacter baumannii 0 0 2 2 2 2
Yeasts 4 4 4
Candida parapsilosis 0 0 2 2 2 2
Candida tropicalis 0 0 2 2 2 
Total 0 19 131 150 150 150
Table III
Distribution of the identified species according to MALDI-TOF MS results when working
with both methods.
MALDI‐TOF MS – matrix-assisted laser desorption/ionization time-of-flight mass spectrometry;
n – number
Organisms
MALDI-TOF
Biotyper scores
< 1.7; 1.7–2.0; ≥ 2
n n n Total
Rapid method
n
Routine method
n
both methods, demonstrating complete consistency 
between the two methods. However, a discrepancy was 
detected between the two methods for 12 (8%) strains, 
with small differences observed in only Gram-positive 
bacteria. Conversely, for the 30 Gram-negative strains, 
100% consistency was observed between the rapid 
method and the MALDI-TOF MS system. Two sam-
ples were terminated without processing because they 
contained more than one type of microorganism (poly-
microbial) and were not evaluated. Therefore, when the 
identification and antibiotic susceptibility tests of all the 
Gram-negative bacteria were compared, no discrepancy 
occurred between the results from either method (of 
the 150 strains, 30 [20%] Gram-negative bacilli contin-
ued to be studied; the same identification and antibiotic 
susceptibility results were obtained with both meth-
ods). No difference was observed between the results 
obtained by both methods for all strains of enterococci 
belonging to Gram-positive bacteria (20 [13.3%] of the 
150 strains). However, when other Gram-positive bac-
teria were evaluated, a small inconsistency (identifica-
tion of different microorganisms at the genus or spe-
cies level using each method) equal to 8% was observed 
between these methods. In addition, this inconsistency 
was also observed in the results obtained for the Gram-
positive strains, which can be regarded as indicative of 
contamination (Table IV).
The agreement for the AST results performed by 
both methods are the same in terms of the MIC values 
(100% of similarity) for most of the antimicrobials (e.g., 
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Gram-positive bacteria 104 (89.7) 12 (10.3) 0
Gram-negative bacteria  30 (100)  0 0
Yeasts   4 (100)  0 0
Total 138 (92) 12 (8) 0
Table IV
Analysis of the compatibility between the identification results of the rapid method 
when compared with the MALDI-TOF MS.
MALDI‐TOF MS – matrix-assisted laser desorption/ionization time-of-flight mass 
spectrometry; n – number
Bacteria Full consistencyn (%)
Misidentified
n (%)
Not identified
n (%)
Amikacin  28 (93.3)  –  2 (6.7)  28 (93.3)  –  2 (6.7)
Ampicillin  18 (19.1)  – 76 (80.9)  18 (19.1)  – 76 (80.9)
Amoxicillin/Clavulanic acid  18 (15.8)  – 96 (84.2)  18 (15.8)  – 96 (84.2)
Aztreonam  18 (60)  1 (3.3) 11 (36.7)  15 (50)  – 15 (50)
Cefepime  20 (66.7)  – 10 (33.3)  14 (46.7)  – 16 (53.3)
Cefoxitin   – 36 (41.9) 50 (58.1)   – 35 (40.7) 51 (59.3)
Ceftazidime  10 (33.3) 10 (33.3) 10 (33.3)  10 (33.3) 10 (33.3) 10 (33.3)
Ceftriaxone  18 (60)  – 12 (40)  18 (60)  – 12 (40)
Ciprofloxacin  82 (66.1)  – 42 (33.9)  66 (53.2) 10 (8.1) 48 (38.7)
Colistin  30 (100)  –  –  30 (100)  –  –
Clindamycin  50 (53.2)  1 (1.1) 43 (45.7)  51 (554.3)  – 43 (45.7)
Daptomycin  71 (75.5) 23 (24.5)  –  65 (69.1) 29 (30.9)  –
Ertapenem  28 (93.3)  –  2 (6.7)  28 (93.3)  –  2 (6.7)
Erythromycin  14 (14.9)  – 80 (85.1)  14 (14.9)  – 80 (85.1)
Fusidic acid  35 (40.7)  – 51 (59.3)  36 (41.9)  – 50 (58.1)
Gentamicin  66 (53.2)  – 58 (46.8)  66 (53.2)  1 (0.8) 57 (50)
Imipenem  28 (93.3)  –  2 (6.7)  28 (93.3)  –  2 (6.7)
Meropenem  28 (93.3)  –  2 (6.7)  28 (93.3)  –  2 (6.7)
Linezolid  94 (100)  –  –  94 (100)  –  –
Oxacillin  12 (12.8)  – 82 (87.2)  12 (12.8)  – 82 (87.2)
Piperacillin/Tazobactam  10 (33.3) 10 (33.3) 10 (33.3)  16 (53.3)  2 (6.7) 12 (40)
Rifampin  62 (66)  – 32 (34)  62 (66)  – 32 (34)
Teicoplanin  94 (100)  –  –  94 (100)  –  –
Tetracycline  35 (40.7)  – 51 (59.3)  35 (40.7)  – 51 (59.3)
Tigecycline  84 (89.4)  8 (8.5) 2 (2.1)  86 (91.5)  6 (6.4)  2 (2.1)
TMP/SX  55 (44.4)  – 69 (55.6)  51 (41.1)  3 (2.4) 70 (56.5)
Vancomycin  94(100)  –  –  94 (100)  –  –
Total 1102 (55.5) 89 (4.5) 793 (40) 1077 (54.3) 96 (4.8) 811 (40.9)
Table V
Distribution of the resistance profiles for Gram-positive and Gram-negative bacteria as a result
of the antibiotic susceptibility testing when both methods were applied.
n – number; I – intermediate; R – resistant; S – susceptible; TMP/SX – Trimethoprim/Sulfamethoxazole
Antibiotics
The rapid method, n (%) The routine method, n (%)
S SRI I R
vancomycin, teicoplanin, ampicillin, and linezolid), 
whereas the lowest agreement value was obtained for 
the piperacillin/tazobactam combination (Table  V). 
However, when all the antibiotic susceptibility results 
between the two methods were examined, the ratio of 
the full agreement was 97.4%, the VME ratio (0.8%) 
was slightly higher than the ME ratio (0.1%), and the 
mE value was found as expected: 33 (1.7%) (Table VI).
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Table VI
Categorical distribution of discrepancies in the antibiotic susceptibility results of the rapid method compared
to the routine method.
n – number; mEs – minor errors; MEs – major errors; TMP/SX – Trimethoprim/Sulfamethoxazole; VMEs – very major errors
Antibiotics Agreementn (%)
mEs
n (%)
MEs
n (%)
VMEs
n (%)
Total
n
Amikacin   30 (100)    30
Ampicillin   94 (100)    94
Amoxicillin/Clavulanic acid  114 (100)    114
Aztreonam   26 (86.7)  1 (3.3)   3 (10) 30
Cefepime   24 (80)    6 (20) 30
Cefoxitin   85 (98.8)  1 (1.2)   86
Ceftazidime   30 (100)    30
Ceftriaxone   30 (100)    30
Ciprofloxacin 108 (87.1) 10 (8.1)   6 (4.8) 124
Colistin   30 (100)    30
Clindamycin   93 (98.9)  1 (1.1)   94
Daptomycin   88 (93.6)  6 (6.4)   94
Ertapenem   30 (100)    30
Erythromycin   94 (100)    94
Fusidic acid   85 (98.8)  1 (1.2)  86
Gentamicin  123 (99.2)  1 (0.8)   124
Imipenem   30 (100)    30
Meropenem   30 (100)    30
Linezolid   94 (100)    94
Oxacillin   94 (100)    94
Piperacillin/Tazobactam   22 (73.3)  8 (26.7)   30
Rifampin   94 (100)    94
Teicoplanin   94 (100)    94
Tetracycline   86 (100)    86
Tigecycline   92 (97.9)  2 (2.1)   94
TMP/SX  120 (96.8)  3 (2.4)   1 (0.8) 124
Vancomycin   94 (100)    94
Total 1934 (97.4) 33 (1.7) 1 (0.1) 16 (0.8) 1984
Discussion
To date, a limited number of studies have been con-
ducted to use rapid methods to determine the type of 
organisms that grow in blood cultures and evaluate 
their antibiotic susceptibility. However, the rapid iden-
tification of infectious agents circulating in patients’ 
blood and the determination of the species and the 
correct antibiotic to be used will shorten the treatment 
time by 12 hours, and reduce the cost. The early iden-
tification of bloodstream infections allows for the early 
modification of antimicrobial treatment and a dimin-
ished need for other diagnostic tests. Thus, patients’ 
hospital stay can be shortened, and expenditures on 
patients can be reduced (Beekmann et al. 2003).
In a study conducted by a group of researchers, 
501  microorganisms from blood-circulating infec-
tions were detected in the patients with bacteremia 
or candidiasis with MALDI-TOF with the Antimicro-
bial Stewardship Team test. MALDI-TOF analysis of 
245 patients in the intervention group and 256 patients 
in the preintervention group showed reductions in the 
identification times (84 hours to 56  hours), effective 
antibiotic treatment times (30 to 20 hours), and opti-
mal antibiotic treatment times (90 to 47  hours) for 
the organism (Huang et al. 2013). Our study reports 
the identification and antibiotic susceptibility tests that 
are much shorter (< 24 hours) than conventional tests 
(routinely > 72 hours). In contrast to routine tests, this 
study achieved 97% success without having to use any 
expensive methods.
In a study (Dodemont et al. 2014), nucleic acid-
based tests were performed on Gram-positive and 
Gram-negative bacteria from blood cultures; the test 
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was designed to rapidly identify multiple bacterial 
strains and the resistance associated with these strains. 
This method was compared with the routine method 
for 117  isolates, and the identification and antibi-
otic resistance markers were reported as correct and 
accurate, achieving 97% and 92% rates of detection of 
patho gens from the blood cultures and reduced labo-
ratory times. In our study, the observed 92% accurate 
identification and 97% antibiotic susceptibility compli-
ance results were similar.
In another study (Mancini et al. 2014), a total of 
102 positive blood cultures were tested with the Veri-
gene BC-GN test, which detected certain Gram-nega-
tive bacteria and selected resistance genes. Ninety-eight 
percent of the isolates were correctly identified, and 
29% were identified as those carrying the resistance 
genes (CTX-M, KPC, VIM, and OXA genes). The 
other researchers (Hill et al. 2014) included 54 blood 
culture samples that gave positive signals between 7 and 
23 hours using the Verigene BC-GN test, and correctly 
identified 51 of these samples as Gram-negative bacilli, 
whereas Mancini et al. (2014)) reported that they cor-
rectly identified the full-length carbapenemase enzyme. 
In a test run, the identification of the organisms was 
reported to be faster than the conventional method by 
an average of 24 hours. The other group (Sothoron et al. 
2015) studied the blood cultures of 126 patients with 
Gram-negative bacteremia using an antimicrobial stew-
ardship program test. In a study evaluating the VITEK 2 
system with the Verigene BC-GN test, the mean sur-
vival rate in the optimal treatment was shorter in the 
post-intervention group than in the pre-intervention 
group (38 to 49 hours, respectively). The rapid method 
in our study does not require any additional costs, 
systems, or devices, and it is 24  hours shorter than 
the method in the abovementioned study. We believe 
our method can be used for all bacteria instead of only 
certain bacteria.
The MALDI-TOF and a VITEK 2 system were used 
together in a study by Machen and coworkers (Machen 
et al. 2014) performed to the same-day identification 
and the full panel antimicrobial susceptibility testing 
of bacteria from a total of 100 positive blood culture 
bottles. Compared to conventional methods, the direct 
results were 94% correctly identified with the VITEK 
system, and the identification and antibiograms were 
concluded on the same day. In our study, direct results 
were also reported, with a high success rate of 94% being 
achieved (without 24 hours of incubation) using 5 ml of 
liquid from the blood culture fluid and without the need 
for a device that adds costs to the conventional method.
In a study conducted by another group of research-
ers (Banerjee et al. 2015), the detection of bacterial and 
fungal resistance genes in the strains directly identi-
fied in 617 positive blood cultures was performed 
using a  direct rapid multiplex PCR (rmPCR). It was 
followed by the evaluation of the treatment duration 
and mortality. The shortest period after Gram stain-
ing needed to appropriate evaluation of antimicrobial 
susceptibility was achieved by rmPCR. These results 
allowed for the reduction of mortality and the use of 
antibiotics. Because we were working with fewer sam-
ples in our study (which would not significantly change 
the results), the rapid delivery of blood culture results 
was critical to the patient; in terms of cost, the cen-
trifugation of blood culture bottles with positive signals 
required no extra cost, and this method was used to 
obtain faster results (< 24 hours).
In a study by Stevenson et al. (2010), a total of 
212 patient samples, 179 of which were positive blood 
cultures and 33 of which were isolated broth species, 
were prepared and processed for MALDI-TOF analysis. 
In this study, 42 strains (12 Propionibacterium acnes and 
seven S. epidermidis) with spectral scores < 1.7 could not 
be identified. Twenty-four strains with scores between 
1.7 and 1.9 were correctly identified (six were S. epi-
dermidis). The strains with scores of 1.9 were correctly 
identified at the species level. Similarly, in our study, 
the species determination and antibiotic susceptibility 
testing of strains from a single-species culture in the 
blood cultures were performed using a rapid method. 
Alternatively, for rapid reporting (97% success) of the 
antibiotic susceptibility results, we used a direct analy-
sis with a centrifugation process. Notably, the use of 
mass spectrometry technology can only be established 
in large laboratories.
The other researchers (Lupetti et al. 2010) stud-
ied 57 blood cultures that were collected from differ-
ent clinics and found to be a single-species culture of 
Gram-positive cocci by Gram staining. The addition 
of saponin in the new procedure was compared with 
the routine method. Discrepancies between the two 
methods were resolved by ID32 Staph or by Rapid ID32 
Strep and E-test. With the new method, 44 (80%) of 
the Gram-positive cocci were detected as CoNS (34 
[62%] S. epidermidis). In our study, unlike the one 
above, not only Gram-positive bacteria but also other 
bacteria and yeasts were studied. In addition, saponin or 
a similar substance was not used in this study. Among 
the identification values obtained by the rapid method, 
the CoNS rate was slightly lower (62%). Although our 
antibiotic susceptibility findings were similar, we nota-
bly had few VMEs, which maybe because of the pres-
ence of gel in the tubes.
In another study (Chen et al. 2015), Gram staining 
was performed after samples were cultured on blood; 
this method was performed on 400 positive-signal 
blood cultures on weekdays between 8:00 am and 
3:00 pm. Samples that were a single species culture after 
the Gram staining were included in the study. While 
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358 (89.5%) isolates were identified correctly by VITEK 
MS, 343 (85.8%) were identified correctly at the spe-
cies level, and 15 (3.7%) were identified correctly at the 
genus level. Of these definitions, 146 (96.1%) isolates 
of 152 Gram-negative bacilli (78 E. coli and 25 Kleb-
siella species isolates) were correctly identified, while 
197 (79.4%) isolates of 248 Gram-positive organisms 
(76 of 95 CoNS and 56 of 58 S. aureus) were correctly 
identified. In our study, Gram-negative bacilli and 
yeasts were correctly identified in 100%, and Gram- 
-positive bacteria were correctly identified in approxi-
mately 90%. These identifications were obtained with-
out any culturing on media or incubation after centrifu-
gation; instead, the identification occurred by loading 
directly into the culture antibiogram device. In addi-
tion, enterococci were also completely identified when 
compared with MALDI-TOF MS.
In one study (Tian et al. 2016), 485 positive speci-
mens were evaluated by injecting various body fluids 
into blood culture bottles. Then, the researchers com-
bined MALDI-TOF MS with a VITEK AST system 
and conducted rapid microbial identification (RMI), 
and rapid multiple AST (RMAST). Then, the RMAST 
results were compared with the standard method 
results. Discrepancies in the MIC values were resolved 
by broth dilution, according to CLSI (2015) guidelines. 
RMI correctly identified Gram-negative and Gram-
positive bacteria (98.9%, and 87.2%, respectively), 
and fungi (75.7%). As a result, the RMI and RMAST 
were completed 18–36 hours in advance of the report 
notification. In our study, only blood cultures were 
evaluated. A  longer centrifugation time with a lower 
speed was utilized. After comparable identification 
and antibiotic susceptibility testing procedures, simi-
lar results were obtained. Our report notifications were 
made within 24 hours.
Recently, in a study conducted by Campigottoa 
et al. (2018), MALDI-TOF MS analysis was used for 
the identification of bacteria directly from blood 
cultures, followed by antibiotic susceptibility tests and 
rapid determination of methicillin-resistance and beta-
lactam-resistance status. A total of 125 positive blood 
cultures sent from various intensive care units were 
included in the study. The VITEK 2 system and appro-
priate AST cards were used to determine the antibiotic 
susceptibility, and standard procedures were applied. 
When compared with the routine method, 91.2% 
were correctly identified at the genus level, 82.4% had 
species-level compatibility, and eight unidentified iso-
lates at the genus level were Gram-positive organisms. 
Gram-negative bacteria were detected at a high species 
level of 100% and 93%, respectively. All four fungal iso-
lates C. albicans, C. parapsilosis, and C. tropicalis were 
correctly identified at the species level. In contrast to 
the above study, in our study, the centrifugation time 
was longer, the rpm was lower, and the bacterial suspen-
sion was prepared and loaded directly onto the Phoenix 
100 instrument. Similar error rates (2.6% in total) and 
agreement (97%) were observed. Furthermore, in our 
study, the goal of reporting results in 24 hours was suc-
cessfully achieved.
Conclusions
The search for methods that do not require addi-
tional financing and are widely available is on-going. 
In this study, 5 ml of blood samples were taken directly 
from blood cultures with positive signals, and the 
results were obtained within 24 hours. It was achieved 
with centrifugation, Gram staining, and an appro-
priate antimicrobial panel (Gram-positive or Gram-
negative). The Gram-negative strains were reported 
with 100% consistency, and the Gram-positive strains 
were reported with 90% consistency among the new 
and routine methods. For the Gram-positive bacteria 
that were inconsistently identified with these methods, 
we believe that further studies in this area will help to 
distinguish pathogenic and nonpathogenic strains. In 
particular, we believe that unnecessary antibiotic treat-
ments can be avoided for patients infected with Gram-
positive bacteria, which can be identified as contami-
nants sooner than Gram-negative bacteria. Due to the 
rapid culture antimicrobial susceptibility testing used in 
this study, antibiotic therapies could begin early, since 
the patients’ blood culture results will be reported very 
quickly (in about 12 hours) without the need for extra 
costs. In addition, since this can shorten the length of 
hospital stay of patients, medical and economic benefits 
will be achieved at the national level. We also believe 
that the volume of the sample taken directly from the 
bottles should be increased (to at least 10 ml) and that 
employees should have sufficient experience; then, the 
efficiency of this method can be higher. However, the 
most crucial limitation of this method is the presence 
of more than one species in the blood cultures (polymi-
crobial cultures). Finally, the rapid method used in the 
study allows obtaining the diagnosis of bloodstream 
infections in a short span of 12 hours and with an accu-
racy of 97% (100% for Gram-negative bacteria).
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